Stockscreener 앱 받기
1.82
8.77%
-0.175
시간 외 거래:
1.82
전일 마감가:
$1.995
열려 있는:
$1.78
하루 거래량:
83,940
Relative Volume:
5.83
시가총액:
$170.55M
수익:
-
순이익/손실:
-
주가수익비율:
-0.7223
EPS:
-2.5197
순현금흐름:
-
1주 성능:
-1.62%
1개월 성능:
-8.08%
6개월 성능:
-18.39%
1년 성능:
-76.36%
1일 변동 폭
$1.78
$1.96
1주일 범위
$1.78
$2.10
52주 변동 폭
$1.10
$8.37
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
1.82 | 68.27M | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-04 | 개시 | H.C. Wainwright | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스
Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks
ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India
ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India
Adlai Nortye Announces Change in Auditing Firm - TipRanks
Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks
Trump Announces Nomination of Howard Lutnick to Serve as US Commerce Secretary, to Run Office of US Trade Representative - AASTOCKS.com
Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat
Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive
CRVO Stock Quote Price and Forecast - CNN
Adlai Nortye Ltd Adr (ANL) 재무 분석
Adlai Nortye Ltd Adr (ANL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.89%
3.74%
자본화:
|
볼륨(24시간):